Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers

被引：3
|
作者：
Weir, MR [1 ]
机构：
[1] Univ Maryland Hosp, Div Renal, Baltimore, MD 21202 USA
来源：
CURRENT HYPERTENSION REPORTS | 2002年 / 4卷 / 05期
关键词：
D O I：
10.1007/s11906-002-0059-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：333 / 335
页数：3
相关论文
共 50 条
  • [1] Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers
    Matthew R. Weir
    Current Hypertension Reports, 2002, 4 : 333 - 335
  • [2] The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction - Introduction
    Williams, GH
    AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (11) : 175S - 176S
  • [3] Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk
    Farsang, Csaba
    VASCULAR HEALTH AND RISK MANAGEMENT, 2011, 7 : 605 - 622
  • [4] Microalbuminuria as a cardiovascular risk factor and the effects of angiotensin II receptor blockers on this factor
    Máthé, L
    Bán, E
    JOURNAL OF HYPERTENSION, 2005, 23 : S379 - S379
  • [5] Angiotensin II Receptor Blockers and the Risk of Dementia
    Goh, Kah Lay
    Douglas, Ian
    Bhaskaran, Krishnan
    Evans, Stephen
    Smeeth, Liam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 170 - 171
  • [6] Angiotensin II Receptor Blockers in the Treatment of the Cardiovascular Disease Continuum
    Chrysant, Steven G.
    CLINICAL THERAPEUTICS, 2008, 30 : 2181 - 2190
  • [7] The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease
    Abramov, Dmitry
    Carson, Peter E.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2012, 13 (03) : 317 - 327
  • [8] Cardiovascular Risk of Olmesartan (Olm) Compared with Other Angiotensin-II Receptor Blockers (ARBs)
    Graham, David J.
    Ding, Xiao
    Saneinejad, Shahin
    Zhou, Esther H.
    Calia, Katlyn
    Levenson, Mark
    Gelperin, Kate
    Rose, Martin
    Hammad, Tarek A.
    MaCurdy, Thomas E.
    Worrall, Chris
    Kelman, Jeffrey A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 162 - 162
  • [9] Angiotensin II receptor blockers
    Thai, H
    Raya, T
    CORONARY ARTERY DISEASE, 1999, 10 (06) : 377 - 381
  • [10] Angiotensin II receptor blockers and cardiovascular outcomes: the evidence now and in the future
    Weber, M
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 : S12 - S16
12345